GENGRAF Side Effects

6723391-5 | Alopecia
on Aug 19, 2009 Female patient from UNITED STATES , weighting 142.1 lb, was diagnosed with prophylaxis against transplant rejection and was treated with Gengraf (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia. Gengraf dosage: Daily.

6723390-3 | Blood Creatinine Increased, Vomiting
Patient was taking Gengraf (View Usage). Patient had the following side effects: blood creatinine increased, vomiting on Dec 23, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 230.2 lb, was diagnosed with renal transplant and. Gengraf dosage: .

6723388-5 | Blood Creatinine Increased, Diabetes Mellitus, Weight Decreased
Adverse event was reported on Jan 20, 2010 by a Female patient taking Gengraf (View Usage) (Dosage: ) was diagnosed with renal transplant and. Location: UNITED STATES , weighting 145.1 lb, After Gengraf was administered, patient had the following side effects: blood creatinine increased, diabetes mellitus, weight decreased.

6723387-3 | Rash
on Oct 23, 2009 Female patient from UNITED STATES , weighting 137.1 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Gengraf (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?). Gengraf dosage: .


6723384-8 | Migraine, Pain, Paraesthesia
on Apr 21, 2010 Male patient from UNITED STATES , weighting 160.1 lb, was diagnosed with psoriasis and was treated with Gengraf (View Usage). Patient had the following side effects: migraine (What is migraine?), pain (What is pain?), paraesthesia. Gengraf dosage: .

6723383-6 | Rash
Patient was taking Gengraf (View Usage). After Gengraf was administered, patient had the following side effects: rash (What is rash?) on Mar 09, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 127.1 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Gengraf dosage: 2 Doses.

6723382-4 | Dental Care
Adverse event was reported on May 27, 2009 by a Male patient taking Gengraf (View Usage) (Dosage: ) was diagnosed with renal transplant and. Location: UNITED STATES , weighting 260.2 lb, Patient experienced the following unwanted or unexpected effects: dental care. During the same period patient was treated with DECLINED LONG LIST (View Declined Long List Review and Declined Long List Label ).

6723379-4 | Renal Pain
on Jul 06, 2009 Male patient from UNITED STATES , weighting 145.1 lb, was diagnosed with renal transplant and was treated with Gengraf (View Usage). Patient had the following side effects: renal pain. Gengraf dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ).

6723378-2 | Dizziness, Gastric Disorder, Influenza Like Illness
on Dec 03, 2009 Male patient from UNITED STATES , weighting 148.1 lb, was diagnosed with aplastic anaemia, hypertension, blood cholesterol increased, anxiety (What is anxiety?), antiviral prophylaxis and was treated with Gengraf (View Usage). After Gengraf was administered, patient had the following side effects: dizziness (What is dizziness?), gastric disorder, influenza like illness. Gengraf dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), FLU (View Flu Review and Flu Label ).

6723377-0 | Tremor
Patient was taking Gengraf (View Usage). Patient experienced the following unwanted or unexpected effects: tremor on Jul 31, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 160.1 lb, . Gengraf dosage: .

6677126-5 | Gastrostomy Tube Insertion
Adverse event was reported on Apr 02, 2010 by a Male patient taking Gengraf (View Usage) (Dosage: ) . Location: UNITED STATES , 68 years of age, Patient had the following side effects: gastrostomy tube insertion.

6231969-0 | Abdominal Discomfort, Abdominal Distension, Abdominal Pain, Abdominal Pain Upper, Nausea
on Mar 11, 2009 Male patient from UNITED STATES , 47 years of age, weighting 160.1 lb, was diagnosed with psoriasis and was treated with Gengraf (View Usage). After Gengraf was administered, patient had the following side effects: abdominal discomfort, abdominal distension, abdominal pain (What is abdominal pain?), abdominal pain upper, nausea (What is nausea?). Gengraf dosage: .

6231964-1 | Rash
on Jul 18, 2008 Female patient from UNITED STATES , weighting 120.1 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Gengraf (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?). Gengraf dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ).

6231963-X | Blood Creatinine Increased, Erectile Dysfunction, Gout
Patient was taking Gengraf (View Usage). Patient had the following side effects: blood creatinine increased, erectile dysfunction (What is erectile dysfunction?), gout (What is gout?) on Aug 12, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 217.2 lb, was diagnosed with heart transplant (What is heart transplant?), diabetes mellitus, prophylaxis against transplant rejection, blood triglycerides, lung disorder, mineral supplementation, vitamin supplementation, cardiovascular disorder and. Gengraf dosage: 100mg + (2) 25 Mg In Morning And 100mg + 25 Mg In The Evening. During the same period patient was treated with GLIBENCLAMIDE (5 Mg, 2 Tabs Every Morning, 1 Tab At Bed Time) (View Glibenclamide Review and Glibenclamide Label ), TELLCETT (View Tellcett Review and Tellcett Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), CALCIUM CITRATE (View Calcium Citrate Review and Calcium Citrate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ).

6231961-6 | Erythema, Rash Papular
Adverse event was reported on Jan 19, 2009 by a Female patient taking Gengraf (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , weighting 126.1 lb, After Gengraf was administered, patient had the following side effects: erythema, rash papular.

6231959-8 | Rash
on Aug 04, 2008 Female patient from UNITED STATES , weighting 120.1 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Gengraf (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?). Gengraf dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ).

6231955-0 | Amnesia, Confusional State
on Feb 10, 2009 Female patient from UNITED STATES , child 10 years of age, weighting 102.1 lb, was diagnosed with focal segmental glomerulosclerosis and was treated with Gengraf (View Usage). Patient had the following side effects: amnesia, confusional state. Gengraf dosage: .

6173659-9 | Herpes Zoster, Immune System Disorder, Pneumonia
Patient was taking Gengraf (View Usage). After Gengraf was administered, patient had the following side effects: herpes zoster, immune system disorder, pneumonia (What is pneumonia?) on Apr 29, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 204.0 lb, was diagnosed with psoriasis and. Gengraf dosage: 10x Day. During the same period patient was treated with ENBREL (50mg Injection 2x Wk) (View Enbrel Review and Enbrel Label ). Patient was hospitalized.

6083149-X | Product Quality Issue
Adverse event was reported on Feb 13, 2009 by a Female patient taking Gengraf (View Usage) (Dosage: 50 Mg Twice Daily By Mouth) was diagnosed with kidney transplant rejection and. Location: UNITED STATES , weighting 143.0 lb, Patient experienced the following unwanted or unexpected effects: product quality issue.

5990876-9 | Graft Versus Host Disease
on Dec 02, 2008 Female patient from UNITED STATES , weighting 112.1 lb, was diagnosed with bone marrow transplant (What is bone marrow transplant?), neoplasm malignant and was treated with Gengraf (View Usage). Patient had the following side effects: graft versus host disease. Gengraf dosage: . During the same period patient was treated with ^LOTS^ DID NOT WANT TO LIST (View ^lots^ Did Not Want To List Review and ^lots^ Did Not Want To List Label ).

5843379-6 | Graft Versus Host Disease
on Aug 04, 2008 Female patient from UNITED STATES , weighting 112.1 lb, was diagnosed with bone marrow transplant (What is bone marrow transplant?), neoplasm malignant and was treated with Gengraf (View Usage). After Gengraf was administered, patient had the following side effects: graft versus host disease. Gengraf dosage: . During the same period patient was treated with ^LOTS^ DID NOT WANT TO LIST (View ^lots^ Did Not Want To List Review and ^lots^ Did Not Want To List Label ).

5806737-1 | Graft Versus Host Disease
Patient was taking Gengraf (View Usage). Patient experienced the following unwanted or unexpected effects: graft versus host disease on Jul 09, 2008 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 120.6 lb, was diagnosed with complications of bone marrow transplant, graft versus host disease and. Gengraf dosage: 100mg Bid Po, 3 Wks On This Lot.

5754336-2 | Nausea
Adverse event was reported on Jan 08, 2008 by a Female patient taking Gengraf (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , weighting 147.1 lb, Patient had the following side effects: nausea (What is nausea?).

5754332-5 | Abdominal Pain Upper, Insomnia
on Jun 15, 2007 Male patient from UNITED STATES , weighting 190.2 lb, was diagnosed with renal transplant and was treated with Gengraf (View Usage). After Gengraf was administered, patient had the following side effects: abdominal pain upper, insomnia. Gengraf dosage: . During the same period patient was treated with PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), BP MEDS (View Bp Meds Review and Bp Meds Label ).

5754328-3 | Rash Macular, Stomach Discomfort
on Feb 19, 2008 Male patient from UNITED STATES , weighting 250.4 lb, was diagnosed with psoriasis and was treated with Gengraf (View Usage). Patient experienced the following unwanted or unexpected effects: rash macular, stomach discomfort. Gengraf dosage: . During the same period patient was treated with EFALIZUMAB (View Efalizumab Review and Efalizumab Label ), MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), SERETIDE (View Seretide Review and Seretide Label ), SALBUTAMOL SULFATE (View Salbutamol Sulfate Review and Salbutamol Sulfate Label ).

5754327-1 | Blood Test Abnormal
Patient was taking Gengraf (View Usage). Patient had the following side effects: blood test abnormal on Jan 17, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 125.1 lb, was diagnosed with renal transplant and. Gengraf dosage: 07-jan-2008 New Bottle Lot# 56763af21 Exp. Nov-2009. During the same period patient was treated with GENGRAF 25MG (07 Jan 2007 New Bottle, Lot#56775af21, Exp. Date Nov-2009) (View Gengraf 25mg Review and Gengraf 25mg Label ).

5754325-8 | Rash
Adverse event was reported on Feb 21, 2008 by a Female patient taking Gengraf (View Usage) (Dosage: Product Discarded) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , weighting 144.1 lb, After Gengraf was administered, patient had the following side effects: rash (What is rash?).

5754321-0 | Arthralgia, Joint Swelling, Muscular Weakness, Musculoskeletal Stiffness
on Jun 13, 2007 Female patient from UNITED STATES , weighting 113.1 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), thyroid disorder, vitamin supplementation and was treated with Gengraf (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, joint swelling, muscular weakness, musculoskeletal stiffness. Gengraf dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), VITAMINS (View Vitamins Review and Vitamins Label ).

5717784-2 | Dyspepsia, Fatigue, Malaise, Myocardial Infarction, Vomiting
on Apr 15, 2008 Male patient from UNITED STATES , weighting 140.1 lb, was diagnosed with renal transplant, blood cholesterol abnormal, cardiovascular event prophylaxis, hypertension, pain (What is pain?) and was treated with Gengraf (View Usage). Patient had the following side effects: dyspepsia, fatigue, malaise, myocardial infarction, vomiting. Gengraf dosage: . During the same period patient was treated with INEGY (View Inegy Review and Inegy Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), GLYCERYL TRINITRATE (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

5673511-9 | Cardiac Failure Congestive, Oxygen Saturation Abnormal
Patient was taking Gengraf (View Usage). After Gengraf was administered, patient had the following side effects: cardiac failure congestive, oxygen saturation abnormal on Mar 12, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 313.3 lb, was diagnosed with renal transplant and. Gengraf dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), NOVOLIN 70/30 (View Novolin 70/30 Review and Novolin 70/30 Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5620444-X | Cardiac Failure
Adverse event was reported on Feb 04, 2008 by a Female patient taking Gengraf (View Usage) (Dosage: ) was diagnosed with renal transplant and. Location: UNITED STATES , weighting 170.2 lb, Patient experienced the following unwanted or unexpected effects: cardiac failure.

5470270-X | Asphyxia, Balance Disorder, Blood Antidiuretic Hormone Increased, Cerebral Ventricle Dilatation, Clonus, Congenital Cutis Laxa, Congenital Musculoskeletal Anomaly, Craniosynostosis, Developmental Delay
on Sep 20, 2007 Male patient from JAPAN , weighting 3.05 lb, was treated with Gengraf (View Usage). Patient had the following side effects: asphyxia, balance disorder, blood antidiuretic hormone increased, cerebral ventricle dilatation, clonus, congenital cutis laxa, congenital musculoskeletal anomaly, craniosynostosis, developmental delay. Gengraf dosage: . During the same period patient was treated with BLOPRESS TABLETS (View Blopress Tablets Review and Blopress Tablets Label ).

5075784-2 | Hallucination, Visual, Restlessness, Tremor
on Aug 07, 2006 Male patient from UNITED STATES , 56 years of age, weighting 134.3 lb, was diagnosed with liver transplant (What is liver transplant?) and was treated with Gengraf (View Usage). After Gengraf was administered, patient had the following side effects: hallucination, visual, restlessness, tremor. Gengraf dosage: 125mg Bid Oral. Patient was hospitalized.

5063899-4 |
Patient was taking Gengraf (View Usage). on Mar 14, 2006 from UNITED STATES Additional patient health information: Male patient , 65 years of age, was diagnosed with transplant and. Gengraf dosage: 25 Mg, 3 Tabs, 2 In 1 D.

5011835-9 | Lip And/or Oral Cavity Cancer, Metastases To Skin
Adverse event was reported on May 18, 2006 by a Male patient taking Gengraf (View Usage) (Dosage: ) was diagnosed with prophylaxis against transplant rejection and. Location: UNITED STATES , 55 years of age, Patient had the following side effects: lip and/or oral cavity cancer, metastases to skin. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ).

4699697-0 | Vocal Cord Paralysis
on Jun 14, 2005 Male patient from , weighting 125.7 lb, was treated with Gengraf (View Usage). After Gengraf was administered, patient had the following side effects: vocal cord paralysis. Gengraf dosage: . Patient was hospitalized.

4697417-7 | Hypercalcaemia
on Nov 17, 2004 Female patient from , weighting 94.80 lb, was diagnosed with hypertension, infection prophylaxis, antifungal prophylaxis, prophylaxis against gastrointestinal ulcer and was treated with Gengraf (View Usage). Patient experienced the following unwanted or unexpected effects: hypercalcaemia. Gengraf dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BACTRIM (View Bactrim Review and Bactrim Label ), NYSTATIN (View Nystatin Review and Nystatin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), MMF (View Mmf Review and Mmf Label ). Patient was hospitalized.

4695395-8 | Abdominal Discomfort
Patient was taking Gengraf (View Usage). Patient had the following side effects: abdominal discomfort on Mar 02, 2005 from Additional patient health information: Female patient , weighting 203.0 lb, was diagnosed with heart transplant (What is heart transplant?) and. Gengraf dosage: 25mg 2 Qam, 3 Qpm.

4677941-3 | Blood Creatine Phosphokinase Increased
Adverse event was reported on Dec 13, 2004 by a Female patient taking Gengraf (View Usage) (Dosage: 175 Mg Po) . Location: , weighting 110.2 lb, After Gengraf was administered, patient had the following side effects: blood creatine phosphokinase increased.

4673399-9 | Blood Creatinine Increased, Diverticulitis
on May 20, 2005 Male patient from , 73 years of age, weighting 173.0 lb, was diagnosed with renal transplant and was treated with Gengraf (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, diverticulitis. Gengraf dosage: 50 Mg Bid Po. During the same period patient was treated with RAPAMUNE (View Rapamune Review and Rapamune Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

4653194-7 | Bradycardia, Convulsion, Dizziness, Syncope, Transplant Rejection
on May 03, 2005 Male patient from , weighting 77.16 lb, was diagnosed with immunosuppression and was treated with Gengraf (View Usage). Patient had the following side effects: bradycardia, convulsion, dizziness (What is dizziness?), syncope, transplant rejection. Gengraf dosage: 85mg Po Bid ~ 2 Months Now. Patient was hospitalized.

4547663-8 | Enterococcal Infection, Klebsiella Infection, Urinary Retention, Urinary Tract Infection
Patient was taking Gengraf (View Usage). After Gengraf was administered, patient had the following side effects: enterococcal infection, klebsiella infection, urinary retention, urinary tract infection (What is urinary tract infection?) on Dec 28, 2004 from Additional patient health information: Male patient , weighting 154.3 lb, . Gengraf dosage: . Patient was hospitalized.